73.09
Ionis Pharmaceuticals Inc Borsa (IONS) Ultime notizie
Is Ionis Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Trade Report & Smart Money Movement Tracker - Trung tâm Dự báo KTTV quốc gia
Hedge Fund and Insider Trading News: Scott Bessent, Paul Tudor Jones, Crispin Odey, Ken Griffin, Millennium Management, Ionis Pharmaceutical Inc (IONS), Chicago Atlantic Real Estate Finance Inc (REFI), and More - Insider Monkey
Ionis Pharmaceuticals director Parshall sells $358,721 in stock By Investing.com - Investing.com Nigeria
Insider Sell Alert: B Parshall Sells 5,000 Shares of Ionis Pharm - GuruFocus
Ionis Pharmaceuticals EVP Birchler sells $1.72m in shares By Investing.com - Investing.com Philippines
Ionis Pharmaceuticals EVP research, Eric Swayze, sells $3901 in IONS stock - Investing.com Australia
Ionis Pharmaceuticals EVP Birchler sells $1.72m in shares - Investing.com
Ionis Pharmaceuticals director Parshall sells $358,721 in stock - Investing.com
Morgan Stanley Raises Price Target for Ionis Pharmaceuticals (IONS) | IONS Stock News - GuruFocus
Ionis Pharmaceuticals Hits New 52-Week High of $73.92 - Markets Mojo
Is Ionis Pharmaceuticals Inc. stock ready for breakoutWeekly Risk Summary & Precise Buy Zone Tips - newser.com
Morgan Stanley Raises Price Target on Ionis Pharmaceuticals to $90 From $86, Keeps Overweight Rating - MarketScreener
Ionis to hold third quarter 2025 financial results webcast - Business Wire
Lobbying Update: $140,000 of IONIS PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative
Ionis Pharmaceuticals stock hits 52-week high at 73.85 USD By Investing.com - Investing.com Nigeria
Ionis Pharmaceuticals stock hits 52-week high at 73.85 USD - Investing.com India
What recovery options are there for Ionis Pharmaceuticals Inc.July 2025 Drop Watch & Long-Term Safe Return Strategies - newser.com
Will Ionis Pharmaceuticals Inc. stock deliver better than expected guidanceIndex Update & Weekly Breakout Stock Alerts - newser.com
Sector ETF performance correlation with Ionis Pharmaceuticals Inc.July 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com
Can Ionis Pharmaceuticals Inc. stock resist market sell offsJuly 2025 Trends & Low Risk Profit Maximizing Plans - newser.com
Published on: 2025-10-15 10:06:19 - newser.com
Why Ionis Pharmaceuticals Inc. stock remains on watchlistsJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com
Can you recover from losses in Ionis Pharmaceuticals Inc.2025 Bull vs Bear & Safe Capital Growth Tips - newser.com
Ionis (IONS) Price Target Hiked Following Positive Zilganersen Trial Results - MSN
Earnings call transcript: Ionis Pharma’s Q2 2025 revenue doubles YoY - Investing.com
Earnings call transcript: Ionis Pharma’s Q2 2025 revenue doubles YoY By Investing.com - Investing.com Canada
Is Ionis Pharmaceuticals Inc. (ISI) stock a fit for income portfoliosPrice Action & Weekly High Return Forecasts - newser.com
Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Growth, Innovation, and a Strategic Pipeline Fueling Investor Interest - DirectorsTalk Interviews
News impact scoring models applied to Ionis Pharmaceuticals Inc.Bull Run & AI Based Buy and Sell Signals - newser.com
Ionis Pharmaceuticals Hits New 52-Week High of $71.87 - Markets Mojo
A Look at Ionis Pharmaceuticals's Valuation Following Strong Phase 3 Data, New Approvals, and Analyst Upgrades - Sahm
Did Multiple FDA Approvals and Ambitious Guidance Just Shift Ionis Pharmaceuticals' (IONS) Investment Narrative? - Sahm
Can technical indicators confirm Ionis Pharmaceuticals Inc.’s reversalProduct Launch & Safe Entry Trade Signal Reports - newser.com
Will Ionis Pharmaceuticals Inc. price bounce be sustainableIndex Update & Fast Momentum Entry Tips - newser.com
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
How Recent Milestones Are Shaping the Outlook and Valuation for Ionis Pharmaceuticals - Yahoo Finance
A Look at Ionis Pharmaceuticals's Valuation Following Pipeline Progress and Strong Innovation Day Updates - Yahoo Finance
Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Raised to $78.00 at Needham & Company LLC - MarketBeat
Eric Swayze Sells 6,849 Shares of Ionis Pharmaceuticals (NASDAQ:IONS) Stock - MarketBeat
Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells $937,375.34 in Stock - MarketBeat
Brett Monia Sells 437 Shares of Ionis Pharmaceuticals (NASDAQ:IONS) Stock - MarketBeat
Ionis Poised To Break Even In 2028 Fueled By A Cadence Of Launches - insights.citeline.com
Ionis Pharmaceuticals stock maintains Buy rating at TD Cowen on pipeline strength - Investing.com Nigeria
Ionis Pharmaceuticals EVP Swayze sells $472k in stock By Investing.com - Investing.com Canada
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):